Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many of the covid-19 vaccines that are under development the Government has ordered in addition to the Pfizer vaccine; and what estimate his Department has made of how many of each type of those vaccines the devolved nations will receive.

The UK Government has secured early access to 355 million vaccines doses through agreements with seven separate vaccine developers, which have been purchased for the whole of the UK. This includes agreements with:

• BioNTech/Pfizer for 40 million doses;
• Oxford/AstraZeneca for 100 million doses;
• GlaxoSmithKline and Sanofi Pasteur for 60 million doses;
• Novavax for 60 million doses;
• Janssen for 30 million doses;
• Valneva for 60 million doses;
• Moderna for 5 million doses.